BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

835 related articles for article (PubMed ID: 18035086)

  • 1. High yield of LMNA mutations in patients with dilated cardiomyopathy and/or conduction disease referred to cardiogenetics outpatient clinics.
    van Tintelen JP; Hofstra RM; Katerberg H; Rossenbacker T; Wiesfeld AC; du Marchie Sarvaas GJ; Wilde AA; van Langen IM; Nannenberg EA; van der Kooi AJ; Kraak M; van Gelder IC; van Veldhuisen DJ; Vos Y; van den Berg MP;
    Am Heart J; 2007 Dec; 154(6):1130-9. PubMed ID: 18035086
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Missense mutations in the rod domain of the lamin A/C gene as causes of dilated cardiomyopathy and conduction-system disease.
    Fatkin D; MacRae C; Sasaki T; Wolff MR; Porcu M; Frenneaux M; Atherton J; Vidaillet HJ; Spudich S; De Girolami U; Seidman JG; Seidman C; Muntoni F; Müehle G; Johnson W; McDonough B
    N Engl J Med; 1999 Dec; 341(23):1715-24. PubMed ID: 10580070
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical and molecular genetic spectrum of autosomal dominant Emery-Dreifuss muscular dystrophy due to mutations of the lamin A/C gene.
    Bonne G; Mercuri E; Muchir A; Urtizberea A; Bécane HM; Recan D; Merlini L; Wehnert M; Boor R; Reuner U; Vorgerd M; Wicklein EM; Eymard B; Duboc D; Penisson-Besnier I; Cuisset JM; Ferrer X; Desguerre I; Lacombe D; Bushby K; Pollitt C; Toniolo D; Fardeau M; Schwartz K; Muntoni F
    Ann Neurol; 2000 Aug; 48(2):170-80. PubMed ID: 10939567
    [TBL] [Abstract][Full Text] [Related]  

  • 4. R25G mutation in exon 1 of LMNA gene is associated with dilated cardiomyopathy and limb-girdle muscular dystrophy 1B.
    Yuan WL; Huang CY; Wang JF; Xie SL; Nie RQ; Liu YM; Liu PM; Zhou SX; Chen SQ; Huang WJ
    Chin Med J (Engl); 2009 Dec; 122(23):2840-5. PubMed ID: 20092787
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dilated cardiomyopathy caused by LMNA mutations. Clinical and morphological studies.
    Bilińska ZT; Sylvius N; Grzybowski J; Fidziańska A; Michalak E; Walczak E; Walski M; Bieganowska K; Szymaniak E; Kuśmierczyk-Droszcz B; Lubiszewska B; Wagner T; Tesson F; Ruzyłło W
    Kardiol Pol; 2006 Aug; 64(8):812-9; discussion 820-1. PubMed ID: 16981056
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel lamin A/C mutation in a family with dilated cardiomyopathy, prominent conduction system disease, and need for permanent pacemaker implantation.
    Hershberger RE; Hanson EL; Jakobs PM; Keegan H; Coates K; Bousman S; Litt M
    Am Heart J; 2002 Dec; 144(6):1081-6. PubMed ID: 12486434
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of mutational hot spots in LMNA encoding lamin A/C in patients with familial dilated cardiomyopathy.
    Perrot A; Hussein S; Ruppert V; Schmidt HH; Wehnert MS; Duong NT; Posch MG; Panek A; Dietz R; Kindermann I; Böhm M; Michalewska-Wludarczyk A; Richter A; Maisch B; Pankuweit S; Ozcelik C
    Basic Res Cardiol; 2009 Jan; 104(1):90-9. PubMed ID: 18795223
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term outcome and risk stratification in dilated cardiolaminopathies.
    Pasotti M; Klersy C; Pilotto A; Marziliano N; Rapezzi C; Serio A; Mannarino S; Gambarin F; Favalli V; Grasso M; Agozzino M; Campana C; Gavazzi A; Febo O; Marini M; Landolina M; Mortara A; Piccolo G; Viganò M; Tavazzi L; Arbustini E
    J Am Coll Cardiol; 2008 Oct; 52(15):1250-60. PubMed ID: 18926329
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel lamin A/C mutations in two families with dilated cardiomyopathy and conduction system disease.
    Jakobs PM; Hanson EL; Crispell KA; Toy W; Keegan H; Schilling K; Icenogle TB; Litt M; Hershberger RE
    J Card Fail; 2001 Sep; 7(3):249-56. PubMed ID: 11561226
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel mutation, Ser143Pro, in the lamin A/C gene is common in finnish patients with familial dilated cardiomyopathy.
    Kärkkäinen S; Heliö T; Miettinen R; Tuomainen P; Peltola P; Rummukainen J; Ylitalo K; Kaartinen M; Kuusisto J; Toivonen L; Nieminen MS; Laakso M; Peuhkurinen K
    Eur Heart J; 2004 May; 25(10):885-93. PubMed ID: 15140538
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutations in the LMNA gene encoding lamin A/C.
    Genschel J; Schmidt HH
    Hum Mutat; 2000 Dec; 16(6):451-9. PubMed ID: 11102973
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical and mutational spectrum in a cohort of 105 unrelated patients with dilated cardiomyopathy.
    Millat G; Bouvagnet P; Chevalier P; Sebbag L; Dulac A; Dauphin C; Jouk PS; Delrue MA; Thambo JB; Le Metayer P; Seronde MF; Faivre L; Eicher JC; Rousson R
    Eur J Med Genet; 2011; 54(6):e570-5. PubMed ID: 21846512
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of novel mutations in LMNA associated with familial forms of dilated cardiomyopathy.
    Stallmeyer B; Koopmann M; Schulze-Bahr E
    Genet Test Mol Biomarkers; 2012 Jun; 16(6):543-9. PubMed ID: 22224630
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional consequences of an LMNA mutation associated with a new cardiac and non-cardiac phenotype.
    Charniot JC; Pascal C; Bouchier C; Sébillon P; Salama J; Duboscq-Bidot L; Peuchmaurd M; Desnos M; Artigou JY; Komajda M
    Hum Mutat; 2003 May; 21(5):473-81. PubMed ID: 12673789
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo and in vitro examination of the functional significances of novel lamin gene mutations in heart failure patients.
    Sylvius N; Bilinska ZT; Veinot JP; Fidzianska A; Bolongo PM; Poon S; McKeown P; Davies RA; Chan KL; Tang AS; Dyack S; Grzybowski J; Ruzyllo W; McBride H; Tesson F
    J Med Genet; 2005 Aug; 42(8):639-47. PubMed ID: 16061563
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of an LMNA-N195K variant of A-type lamins results in cardiac conduction defects and death in mice.
    Mounkes LC; Kozlov SV; Rottman JN; Stewart CL
    Hum Mol Genet; 2005 Aug; 14(15):2167-80. PubMed ID: 15972724
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Cardiac manifestations of laminopathies].
    Brette S; Penisson-Besnier I; Dupuis JM; Bonne G; Victor J
    Arch Mal Coeur Vaiss; 2004 Oct; 97(10):973-7. PubMed ID: 16008174
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thymopoietin (lamina-associated polypeptide 2) gene mutation associated with dilated cardiomyopathy.
    Taylor MR; Slavov D; Gajewski A; Vlcek S; Ku L; Fain PR; Carniel E; Di Lenarda A; Sinagra G; Boucek MM; Cavanaugh J; Graw SL; Ruegg P; Feiger J; Zhu X; Ferguson DA; Bristow MR; Gotzmann J; Foisner R; Mestroni L;
    Hum Mutat; 2005 Dec; 26(6):566-74. PubMed ID: 16247757
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and functional characterization of a novel mutation in lamin a/c gene in a multigenerational family with arrhythmogenic cardiac laminopathy.
    Forleo C; Carmosino M; Resta N; Rampazzo A; Valecce R; Sorrentino S; Iacoviello M; Pisani F; Procino G; Gerbino A; Scardapane A; Simone C; Calore M; Torretta S; Svelto M; Favale S
    PLoS One; 2015; 10(4):e0121723. PubMed ID: 25837155
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lamin A/C mutation is independently associated with an increased risk of arterial and venous thromboembolic complications.
    van Rijsingen IA; Bakker A; Azim D; Hermans-van Ast JF; van der Kooi AJ; van Tintelen JP; van den Berg MP; Christiaans I; Lekanne Dit Deprez RH; Wilde AA; Zwinderman AH; Meijers JC; Grootemaat AE; Nieuwland R; Pinto YM; Pinto-Sietsma SJ
    Int J Cardiol; 2013 Sep; 168(1):472-7. PubMed ID: 23073275
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 42.